Compare COO & CIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COO | CIB |
|---|---|---|
| Founded | 1980 | 1945 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 14.5B |
| IPO Year | N/A | 1995 |
| Metric | COO | CIB |
|---|---|---|
| Price | $83.71 | $67.57 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 5 |
| Target Price | ★ $88.55 | $47.75 |
| AVG Volume (30 Days) | ★ 2.4M | 300.5K |
| Earning Date | 12-04-2025 | 02-19-2026 |
| Dividend Yield | N/A | ★ 6.05% |
| EPS Growth | N/A | ★ 22.14 |
| EPS | 1.87 | ★ 1.96 |
| Revenue | $4,092,400,000.00 | ★ $6,289,868,892.00 |
| Revenue This Year | $6.56 | $33.27 |
| Revenue Next Year | $5.32 | $7.26 |
| P/E Ratio | $45.09 | ★ $9.34 |
| Revenue Growth | 5.06 | ★ 15.25 |
| 52 Week Low | $61.78 | $31.78 |
| 52 Week High | $100.24 | $68.60 |
| Indicator | COO | CIB |
|---|---|---|
| Relative Strength Index (RSI) | 63.17 | 69.15 |
| Support Level | $80.23 | $62.44 |
| Resistance Level | $83.64 | $68.60 |
| Average True Range (ATR) | 1.38 | 1.44 |
| MACD | -0.21 | 0.29 |
| Stochastic Oscillator | 71.73 | 88.12 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.